The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-Methyl-N-(4-phenoxyphenyl)-3-methoxybenzenesulfonamide ID: ALA3971739
PubChem CID: 134153112
Max Phase: Preclinical
Molecular Formula: C20H19NO4S
Molecular Weight: 369.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc(S(=O)(=O)N(C)c2ccc(Oc3ccccc3)cc2)c1
Standard InChI: InChI=1S/C20H19NO4S/c1-21(26(22,23)20-10-6-9-19(15-20)24-2)16-11-13-18(14-12-16)25-17-7-4-3-5-8-17/h3-15H,1-2H3
Standard InChI Key: HYQBXEGPCIBWGS-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
2.6579 -23.7605 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8726 -22.9722 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.0826 -23.1804 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8694 -22.1592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1587 -21.7549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1541 -20.9396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8583 -20.5251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5690 -20.9295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5736 -21.7447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5956 -23.3688 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2950 -22.9451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2761 -22.1282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9755 -21.7046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6897 -22.0937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7085 -22.9105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0091 -23.3384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3891 -21.6700 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1073 -22.0632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8067 -21.6395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5209 -22.0327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5397 -22.8496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8403 -23.2733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1262 -22.8801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6145 -24.1857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4443 -20.5394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7395 -20.9530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
4 9 2 0
2 10 1 0
4 2 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
18 23 2 0
17 18 1 0
14 17 1 0
10 11 1 0
10 24 1 0
25 26 1 0
6 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 369.44Molecular Weight (Monoisotopic): 369.1035AlogP: 4.31#Rotatable Bonds: 6Polar Surface Area: 55.84Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.03CX LogD: 4.03Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.65Np Likeness Score: -1.32
References 1. Yamada A, Kazui Y, Yoshioka H, Tanatani A, Mori S, Kagechika H, Fujii S.. (2016) Development of N-(4-Phenoxyphenyl)benzenesulfonamide Derivatives as Novel Nonsteroidal Progesterone Receptor Antagonists., 7 (12): [PMID:27994732 ] [10.1021/acsmedchemlett.6b00184 ]